Clinical Trial Update: Mosunetuzumab Consolidation Therapy After autoSCT in r/r Aggressive B Cell Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating mosunetuzumab consolidation after autologous stem cell transplantation in relapsed/refractory aggressive B-cell lymphoma is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aggressive B-cell Lymphoma
• B-cell Lymphoma
• Diffuse Large B-cell Lymphoma
• Follicular Lymphoma
• High-grade B-cell Lymphoma
• Transformed Lymphoma

Drugs mentioned

• Mosunetuzumab (mosunetuzumab)

Snippet

Sponsor: Washington University School of Medicine | Conditions: B Cell Lymphoma, Aggressive Lymphoma | Phase 1 | Status: RECRUITING